Boston University Slideshow Title Goes Here District Prevalence of Unsuppressed HIV in South African Women: Monitoring Programme Performance and Progress.

Slides:



Advertisements
Similar presentations
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Advertisements

Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
AIDS Turning the Tide Together IAS Satellite: Where the Tide Will Turn: How is Community Level Participation Most Effective in Turning the Tide?
Know Your epidemic: The value of population-based household surveys Eva Kiwango Senior Strategic Information Advisor United Nations Joint Programme on.
The Implementation of the WHO Asia Pacific Treatment Metrics Dr. YU, Dongbao WHO Regional Office for the Western Pacific 20 July, 2014 Antiretroviral Treatment.
Moving to the final chapter of the AIDS epidemic.
CD4 assessment among newly diagnosed HIV-infected pregnant women in India’s National Prevention of Parent to Child Transmission Programme (PPTCT) Implications.
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University July 17, 2011 The first step is admitting you have a problem.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
Modeling ‘test and treat’ for HIV in South Africa Jan AC Hontelez 1,2,3, Mark N Lurie 4, Till Bärnighausen 3,5, Roel Bakker 1 Rob Baltussen 2, Frank Tanser.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
ARV-Based Prevention: Perspective from Epidemiology & Modelling Tim Hallett Imperial College London.
Copyright © 2009 Pearson Addison-Wesley. All rights reserved. Millennium Development Goals.
Prevalence and risk factors for self-reported sexually transmitted infections among adults in the Diepsloot informal settlement, Johannesburg, South Africa.
STRATEGIC INFORMATION FOR ACTION IN VIET NAM 6 th Viet Nam National Scientific Conference 24 November 2015 Ha Noi, Viet Nam Amitabh Bipin SUTHAR, PharmD,
Global Monitoring Framework for Elimination of New HIV Infections among Children Priscilla Akwara, PhD Senior Adviser, Statistics & Monitoring UNICEF,
HIV Drug Resistance Surveillance Satellite Session: HIV Drug Resistance Surveillance and Control: a Global Concern Silvia Bertagnolio, MD WHO,
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
Beyond Counting – Using HIV Surveillance Data to Monitor Linkage to Care Following Release from Corrections Liza Solomon DrPH, MHS 9 th Academic and Health.
Health economics of workplace HIV programmes A cost benefit analysis of Anglo Coal’s ART programme Gesine Meyer-Rath 1,2,3, Jan Pienaar 4, Brian Brink.
Boston University Slideshow Title Goes Here Eliminating CD4 thresholds in South Africa will not lead to large increases in persons receiving ART without.
Peter D Ghys*, Mary Mahy*, Jeff Eaton**, Samir Bhatt**,
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
HIV System Assessment with Longitudinal Treatment Cascade in KwaZulu-Natal, South Africa Noah Haber,1 Frank Tanser,2 Kevindra Naidu,2 Tinofa Mutevedzi,2.
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Is retention on ART underestimated due to patient transfers
Differentiated Service Delivery: Innovating for Impact
Bhutan Last updated: September 2016.
Central American Certificate Course: HIV Monitoring and Evaluation for HIV/AIDS Policy and Program Management BZ Unit 2 – Post test CR ES GT NI PA January.
HIV treatment cascade analysis for people who inject drugs in Ukraine: identifying the correlates of HIV care outcomes Kostyantyn Dumchev1, Olga Varetska2,
Zimbabwe’s shift towards treat all: national country context
Singapore Last updated: November 2016.
Mongolia Last updated: April 2016.
Using programme M&E data for Surveillance in Nepal: Challenges and Opportunities Name of Author(s): Biwesh Ojha(1)
Immediate HIV treatment prevents new infections: causal evidence on the real-world impact of immediate vs. deferred ART in rural South Africa Catherine.
World Health Organization
Key Affected Populations
Utilizing research as an opportunity to strengthen
The Last Mile to EMTCT: Are we there yet?
International AIDS Economics Network (IAEN) Conference
South African HIV Care Cascades Data Sources
Finding the right target population for PrEP The cost-effectiveness of PrEP provision to adolescents and young women in South Africa Gesine Meyer-Rath1,2,
IAEN Conference (20 July 2018)
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
WHO 2015 GUIDELINES AND FAST TRACKING TOWARDS : Regional perspective
Knowing your epidemic and knowing your response – maximising routinely collected data to measure and monitor HIV epidemics in sub-Saharan Africa Monitoring.
Philippines Last updated: August 2018.
From trials to programmes: Lessons learned from four trials of Universal Testing and Treatment (UTT) in Sub-Saharan Africa 24th July 2018 Estimates of.
Key Affected Populations
Poster WP41; Contact: David A. Katz,
Needs Assessment Slides for Module 4
Papua New Guinea.
Data Hub for Asia-Pacific Review in slides Philippines
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Contents - HIV global slides
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Progress on Voluntary Medical Male Circumcision for HIV prevention and How VMMC fits into UNAIDS ' ' target Julia Samuelson, Nurse epidemiologist.
Trends in the HIV incidence rate following ART scale-up in a rural and hyper-endemic South Africa population (2004–2015) Alain Vandormael, PhD School of.
Bhutan Last updated: July 2018.
TRACE INITIATIVE: Overview
Japan Last updated: April 2019.
Illustrative Cluster Detection and Response Strategy
Start Free, Stay Free, AIDS Free
Update on global progress in ART
For a healthy Zambia.
Presentation transcript:

Boston University Slideshow Title Goes Here District Prevalence of Unsuppressed HIV in South African Women: Monitoring Programme Performance and Progress Towards Jacob Bor 1,2, Alana Brennan 1,2, Matthew Fox 1,2, Mhairi Maskew 2, Wendy Stevens 3, Sergio Carmona 3, Bill MacLeod 1,2 1 Department of Global Health, Boston University School of Public Health, USA, 2 Health Economics and Epidemiology Research Office, University of Witwatersrand, South Africa, 3 National Health Laboratory Service, South Africa and Department of Molecular Medicine and Haematology, University of the Witwatersrand Funded by NIAID R01 AI115979, NIMH

Boston University Slideshow Title Goes Here Monitoring progress to  How do we measure success?  How do we identify areas of unmet need?

Boston University Slideshow Title Goes Here Monitoring progress to  How do we measure success?  How do we identify areas of unmet need?  Traditional approach: the conditional cascade of care

Boston University Slideshow Title Goes Here Conditional Cascade of Care 90% tested 90% ART | tested 90% VL<1000 | tested, ART

Boston University Slideshow Title Goes Here Monitoring progress to  How do we measure success?  How do we identify areas of unmet need?  Traditional approach: the conditional cascade of care  Problem 1: selection bias implies moving targets  Patients not yet tested likely have lower demand for lifelong ART  As countries scale up “treat all”, testing and linkage will increase, but ART initiation and viral suppression – conditional on testing – may fall  Comparisons over time and and space may be misleading  The potential for selection bias is quite real…

Boston University Slideshow Title Goes Here Lower ART uptake at higher CD4 counts Source: Chiu et al. (poster at AIDS 2016), Africa Centre for Population Health Proportion starting ART in 6 months

Boston University Slideshow Title Goes Here Monitoring progress to  How do we measure success?  How do we identify areas of unmet need?  Traditional approach: the conditional cascade of care  Problem 1: selection bias implies moving targets  Problem 2: cascade does not capture prevention  The denominator of the cascade is the HIV-infected population  But we have techniques to reduce % of population that is HIV-infected: Condoms, PreP, MMC, Secondary Schooling, TasP

Boston University Slideshow Title Goes Here Monitoring progress to  How do we measure success?  How do we identify areas of unmet need?  Traditional approach: the conditional cascade of care  Problem 1: selection bias implies moving targets  Problem 2: cascade does not capture prevention  Problem 3: facility- not population-based perspective  Cascade designed based on what can be monitored at facility level.  But our ultimate goals – reduction of incidence, morbidity, and mortality – are population-based goals.

Boston University Slideshow Title Goes Here Monitoring progress to  How do we measure success?  How do we identify areas of unmet need?  Traditional approach: the conditional cascade of care  Problem 1: selection bias implies moving targets  Problem 2: cascade does not capture prevention  Problem 3: facility- not population-based perspective  A public health measurement challenge  How can we best measure programme performance and unmet need when population health impact has a significant lag?

Boston University Slideshow Title Goes Here Inverting the Cascade of Care Total Population HIV+, suppressed Life expectancy ~HIV-negatives HIV transmission close to zero HIV+, unsuppressed High risk for HIV transmission Morbidity, mortality if treatment is substantially delayed Incidence

Boston University Slideshow Title Goes Here Population-based key indicators 1. Population prevalence of unsuppressed HIV  # HIV-infected and VL>1000 / # total population  Unmet need for HIV treatment and prevention services  Key causal determinant of HIV morbidity and mortality  Key causal determinant of HIV incidence (direct/indirect) 2. Percent suppressed in HIV-infected population  # HIV-infected and VL<1000 / # HIV-infected  Programme performance for the treatment programme  “Effective coverage”

Boston University Slideshow Title Goes Here Objective 1.Measure programme performance and unmet need for HIV services at a population level using routine programme and surveillance data 2.Describe geographic variability in programme performance and unmet need in South Africa

Boston University Slideshow Title Goes Here Data sources  District level, n=52  N, Number of women ages  South African Census, 2011  p, HIV prevalence in pregnant women  Antenatal Surveillance HIV Prevalence estimates, pooled 2011/2012  r, Ratio of prevalence in pregnant vs. all women,  HSRC National Survey 2012 (national estimate)  A, Number of patients receiving ART  District Health Information System 2012  v, Proportion of patients virally suppressed  National Health Laboratory Services, 2012  De-duplicated through novel record linkage, NHLS National HIV Cohort

Boston University Slideshow Title Goes Here Methods  # HIV-infected = N*p/r  # HIV-infected, suppressed = A*v  Unsuppressed HIV prevalence = (N*p/r – A*v) / N  Percent suppressed in HIV-infected = (A*v) / (N*p/r)  Assumptions  Ratio r is constant across districts, apart from demographics  No patients are virally suppressed without treatment  Patients who are not virally monitored have same probability of viral suppression as patients who are virally monitored.

Boston University Slideshow Title Goes Here Population viral suppression Substantial heterogeneity in population viral suppression

Boston University Slideshow Title Goes Here Population viral suppression

Boston University Slideshow Title Goes Here Population viral suppression Viral suppression highest in high- prevalence districts.

Boston University Slideshow Title Goes Here Population viral suppression Viral suppression highest in high- prevalence districts. Many districts far from target.

Boston University Slideshow Title Goes Here Unsuppressed HIV prevalence

Boston University Slideshow Title Goes Here Unsuppressed HIV prevalence ART scale-up has led to a reduction in the proportion of the population at risk for transmitting HIV.

Boston University Slideshow Title Goes Here Unsuppressed HIV prevalence vs. total HIV prevalence

Boston University Slideshow Title Goes Here Unsuppressed HIV prevalence vs. total HIV prevalence Success of ART programme

Boston University Slideshow Title Goes Here Unsuppressed HIV prevalence vs. total HIV prevalence Unmet need for HIV services

Boston University Slideshow Title Goes Here Unsuppressed HIV prevalence vs. total HIV prevalence Unmet need for HIV services Hardest to reach Highest transmission risk Performance on ART unknown

Boston University Slideshow Title Goes Here Ranking Districts with the highest HIV prevalence are not the districts with the highest unsuppressed HIV prevalence.

Boston University Slideshow Title Goes Here Districts with the highest HIV prevalence are not the districts with the highest unsuppressed HIV prevalence. Ranking

Boston University Slideshow Title Goes Here Districts with the highest HIV prevalence are not the districts with the highest unsuppressed HIV prevalence. Ranking

Boston University Slideshow Title Goes Here Conclusions  Population viral suppression and unsuppressed HIV prevalence are easily-interpretable measures of program performance and unmet need at the population level.  Can be estimated in routine program and surveillance data, including NHLS National Patient Cohort.  Large variability in population viral suppression presents opportunity to learn from high-performing districts.  Districts with greatest unmet need were not those with highest HIV prevalence, suggesting successful targeting but also a need for renewed focus on districts with high prevalence of unsuppressed HIV.

Boston University Slideshow Title Goes Here Thank you and Acknowledgments  Patients, care providers, and NHLS staff  Sue Candy and colleagues at the NHLS CDW  Research colleagues at BUSPH and HE 2 RO  National Department of Health  Funders  NIH (NIAID, NIMH)  PEPFAR  USAID